GOLDLINE PHARMACEUTICAL LIMITE Share Price

₹ 31.20

+₹0.70 (2.30%)
1D
Last updated 29 Oct, 2026, 13:06 IST
BSE: 544759
|
Pharmaceuticals

GOLDLINE PHARMACEUTICAL LIMITE Share Price Today

As of 29 Oct 2026, GOLDLINE PHARMACEUTICAL LIMITE share price is ₹31.20. The stock opened at ₹31.10, compared to its previous close of ₹30.50. During today's trading session, GOLDLINE PHARMACEUTICAL LIMITE share price moved in the range of ₹31.10 to ₹31.20, with an average price of ₹31.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹28.13 and a high of ₹60.00.


₹31.10
2.30% up today
₹31.20
1D LOW
1D HIGH

GOLDLINE PHARMACEUTICAL LIMITE Stock Insights

Stock Performance
OutperformingBeat Nifty by 3.19 % in last 1 month
Shareholding Pattern
PromoterPromoter increased stake by 3.93%
Shareholding Pattern
DIIDII decreased stake by 98.80%
Shareholding Pattern
FIIFII decreased stake by 93.94%
Volume
6,000
Average traded price
₹31.15
Last traded time
01:06:46 29 Oct
Last traded quantity
3,000

Circuit
L
H
₹24.40
₹36.60
52-week
L
H
₹28.13
₹60.00
Mkt Cap Cr
31.66

P/E
0.0

P/B
0.0

ROA
16.84%
ROE
39.26%

ROCE
29.32%

Quick Ratio
1.64

EV/EBITDA
0.0
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Goldline Pharmaceutical outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Goldline Pharmaceutical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,282.9534.855.0511.19%13.74%17.33%2.3121.18
Divis Laboratories2,51,611.1286.7815.1414.6%15.32%19.56%3.557.29
Torrent Pharmaceuticals1,75,182.2282.649.444.7%11.42%11.37%0.7533.68
Zydus Lifesciences1,16,907.4525.354.298.57%18.59%17.35%0.9115.39
Laurus Labs1,15,616.01106.0421.8110.38%16.77%16.14%0.6854.44
Cipla1,09,870.4038.213.087.75%11.27%14.95%2.518.58
Dr. Reddy's Laboratories1,08,925.7839.472.814.79%7.21%8.58%1.3518.49
Mankind Pharma95,082.9845.325.837.82%12.76%14.68%0.7425.11
Aurobindo Pharma93,959.2125.322.486.34%9.25%11.76%1.1511.7
Lupin89,585.9916.244.0214.47%23.76%24.88%1.429.54

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GOLDLINE PHARMACEUTICAL LIMITE Company Background

ISIN
INE1CLW01015
Sector Market Cap
₹ 31.66 Cr

GOLDLINE PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: GOLDLINE PHARMACEUTICAL LIMITE reported revenue of ₹31.20 crore in FY26 vs ₹28.06 crore in FY25. It showed an increase of 11.19% on a yearly basis.
  • Operating Profit: GOLDLINE PHARMACEUTICAL LIMITE reported an operating profit of ₹5.39 crore in FY26 vs ₹3.86 crore in FY25. It showed an increase of 39.64% on a year-on-year basis.
  • Net Profit: GOLDLINE PHARMACEUTICAL LIMITE reported a net profit of ₹4.12 crore in FY26 vs ₹2.83 crore in FY25. It showed an increase of 45.58% on a yearly basis.
Know more
Promoters
59.54%
FII
0.31%
Other DII
0.09%
Retail and other
40.05%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
May 20265.16%
Sep 20260.31%
1 day
--

1 week
--

1 month
--

1 year
--

3 years
--

5 years
--
Day
Open / Close
Change %
28 Oct 26
₹30.50 / ₹30.50
-7.52%

27 Oct 26
₹31.89 / ₹32.98
+3.09%

26 Oct 26
₹31.99 / ₹31.99
+6.28%

23 Oct 26
₹30.10 / ₹30.10
+0.40%
Show more

GOLDLINE PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹31.20₹28.06₹23.57₹19.85
Other Income₹0.00₹0.00₹0.00₹0.00
Total Revenue₹31.20₹28.06₹23.57₹19.85
Total Expenses₹25.81₹24.20₹21.04₹19.45
Profit Before Tax₹5.39₹3.86₹2.53₹0.40
Tax₹1.27₹1.02₹0.72₹0.14
Profit After Tax₹4.12₹2.83₹1.81₹0.26
EPS - Basic₹5.97₹4.11₹3.01₹0.43
EPS - Diluted₹5.97₹4.11₹3.01₹0.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.39₹3.86₹2.53₹0.40
Income before WC changes₹6.94₹5.92₹4.35₹2.40
Change in Assets-₹3.41-₹2.56-₹1.91-₹0.52
Change in Liabilities₹0.26₹0.73₹0.69₹0.55
Change in WC-₹3.15-₹1.83-₹1.23₹0.03
Cash flow from Operations₹2.81₹3.18₹2.92₹2.39
Cash flow from Investing-₹0.06₹0.16-₹1.11-₹1.03
Cash flow from Financing-₹3.40-₹2.89-₹1.08-₹1.44
Total Cash Flow-₹0.65₹0.45₹0.74-₹0.09
Cash (Start of the year)₹1.24₹0.79₹0.05₹0.14
Cash (End of the year)₹0.59₹1.24₹0.79₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.82₹2.93₹3.43₹2.57
Current Assets₹26.05₹23.35₹19.50₹16.82
Total Assets₹28.87₹26.28₹22.93₹19.39
Current Liabilities₹12.11₹11.77₹10.17₹9.00
Net Current Asset₹13.93₹11.58₹9.33₹7.83
Non-Current Liabilities₹2.51₹4.16₹4.90₹4.50
Equity Capital₹14.25₹10.35₹7.87₹5.89
Total Equity & Liabilities₹28.87₹26.28₹22.93₹19.39
* All values are in INR Crore
Qty
Bid
3000
31.2
3000
30.51
6000
27.66
3000
26
3000
25.79
Ask
Qty
32.49
3000
32.5
3000
32.8
3000
32.9
3000
32.99
3000
Bid Total: 18000
Ask Total: 15000
Buy orders: 55%
Sell orders: 45%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
40.37
Neutral

ATR (14)
1.67
Neutral

STOCH(9,6)
35.43
Neutral

STOCH RSI (14)
42.36
Neutral

ADX(9)
19.99
Bullish

UO(9)
52.72
Neutral

ROC(12)
-7.58
Bearish

WillR(14)
-64.57
Neutral
Period
Simple value
Exponential vaue

5D
31.11
31.41

10D
31.58
31.63

20D
31.85
32.42

50D
36.01
35.02

100D
39.64
30.5
Volume trend — traded volume by day
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
23 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GOLDLINE PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

GOLDLINE PHARMACEUTICAL LIMITE Returns Calculator

GOLDLINE PHARMACEUTICAL LIMITE Share Price FAQs










Please be aware that GOLDLINE PHARMACEUTICAL LIMITE stock prices are subject to continuous fluctuations due to various factors.